Epigenetic Modulation of Solid Tumors as a Novel Approach for Cancer Immunotherapy
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 32 (5) , 473-478
- https://doi.org/10.1053/j.seminoncol.2005.07.005
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidineCancer Research, 2004
- Escape from immunotherapy: possible mechanisms that influence tumor regression/progressionCancer Immunology, Immunotherapy, 2004
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- Current developments of immunotherapy in the clinicCurrent Opinion in Immunology, 2004
- Epigenetic targets for immune intervention in human malignanciesOncogene, 2003
- Cancer/testis‐associated genes: Identification, expression profile, and putative functionJournal of Cellular Physiology, 2003
- HLA class I antigen abnormalities and immune escape by malignant cellsSeminars in Cancer Biology, 2002
- Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cellsBlood, 2000
- Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responsesProceedings of the National Academy of Sciences, 2000
- Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanomaInternational Journal of Cancer, 1997